Skip to main content

Zenas BioPharma, Inc.

ZBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001953926

No open-market purchases or sales by Zenas BioPharma, Inc. insiders were filed in the last 90 days; 144 institutions reported holding it in 13F filings for Q2 2026, worth $1.55B in total; no superinvestor holds it.

Members of Congress who traded ZBIO

No member of Congress has reported a trade in Zenas BioPharma, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.